BPD Saturation TARgeting

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

February 1, 2023

Study Completion Date

September 1, 2023

Conditions
Bronchopulmonary DysplasiaChronic Lung Disease of PrematurityChronic Lung Disease
Interventions
OTHER

LOWER oxygen saturation target group

We will randomize infants with moderate or severe BPD to lower SpO2 target ranges. The study team will then use novel technology to monitor infants starting at randomization, continuing after discharge and until 6 months corrected age, titrating supplemental oxygen to achieve these target SpO2 ranges.

OTHER

HIGHER oxygen saturation target group

We will randomize infants with moderate or severe BPD to higher SpO2 target ranges. The study team will then use novel technology to monitor infants starting at randomization, continuing after discharge and until 6 months corrected age, titrating supplemental oxygen to achieve these target SpO2 ranges.

Trial Locations (3)

19104

Children's Hospital of Philadelphia, Philadelphia

University of Pennsylvania, Philadelphia

19107

Pennsylvania Hospital, Philadelphia

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

lead

Children's Hospital of Philadelphia

OTHER

NCT03385330 - BPD Saturation TARgeting | Biotech Hunter | Biotech Hunter